In the present study, the treatment of SY and HSYA is able to decrease serum ALT levels, and reduce lipid droplets accumulation in the liver of DIO mice, indicating the protective effect of SY and HSYA against HFD-induced NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.